{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:13:09Z","timestamp":1707523989454},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"DOI":"10.7759\/cureus.44533","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T15:26:17Z","timestamp":1693581977000},"source":"Crossref","is-referenced-by-count":0,"title":["Metastatic Leptomeningeal Carcinomatosis From Primary Lobular Breast Cancer Found in a Medical School Cadaveric Dissection"],"prefix":"10.7759","author":[{"given":"Mary C","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary B","family":"Downs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Stephen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.01.020","article-title":"Leptomeningeal carcinomatosis in patients with breast cancer","volume":"135","author":"Franzoi MA","year":"2019","unstructured":"Franzoi MA, Hortobagyi GN. Leptomeningeal carcinomatosis in patients with breast cancer. Crit Rev Oncol Hematol. 2019, 135:85-94. 10.1016\/j.critrevonc.2019.01.020","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/his.12576","article-title":"Skull bone metastasis with adjacent leptomeningeal involvement from pleomorphic lobular carcinoma of the breast","volume":"66","author":"Chen LY","year":"2015","unstructured":"Chen LY, Ni YB, Lacambra MD, Lee WC, Ho KK, Tse GM. Skull bone metastasis with adjacent leptomeningeal involvement from pleomorphic lobular carcinoma of the breast. Histopathology. 2015, 66:1051-3. 10.1111\/his.12576","journal-title":"Histopathology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7731","article-title":"Ommaya reservoir insertion: a technical note","volume":"12","author":"Magill ST","year":"2020","unstructured":"Magill ST, Choy W, Nguyen MP, McDermott MW. Ommaya reservoir insertion: a technical note. Cureus. 2020, 12:e7731. 10.7759\/cureus.7731","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-386456-7.03204-4","article-title":"Invasive breast carcinoma","author":"Sahin A","year":"2014","unstructured":"Sahin A, Zhang, H. Invasive breast carcinoma. Pathobiology of Human Disease. McManus LM, Mitchell RN (ed): Academic Press, Cambridge (MA); 2014. 934-51. 10.1016\/B978-0-12-386456-7.03204-4"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1996.tb02109.x","article-title":"E-cadherin gene mutations in signet ring cell carcinoma of the stomach","volume":"87","author":"Muta H","year":"1996","unstructured":"Muta H, Noguchi M, Kanai Y, Ochiai A, Nawata H, Hirohashi S. E-cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpn J Cancer Res. 1996, 87:843-8. 10.1111\/j.1349-7006.1996.tb02109.x","journal-title":"Jpn J Cancer Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3892\/or.2015.3935","article-title":"Screening of differential microRNA expression in gastric signet ring cell carcinoma and gastric adenocarcinoma and target gene prediction","volume":"33","author":"Chen J","year":"2015","unstructured":"Chen J, Sun D, Chu H, et al.. Screening of differential microRNA expression in gastric signet ring cell carcinoma and gastric adenocarcinoma and target gene prediction. Oncol Rep. 2015, 33:2963-71. 10.3892\/or.2015.3935","journal-title":"Oncol Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-007-9340-4","article-title":"Breast cancer leptomeningeal metastasis--the role of multimodality treatment","volume":"84","author":"Rudnicka H","year":"2007","unstructured":"Rudnicka H, Niwi\u0144ska A, Murawska M. Breast cancer leptomeningeal metastasis--the role of multimodality treatment. J Neurooncol. 2007, 84:57-62. 10.1007\/s11060-007-9340-4","journal-title":"J Neurooncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-012-0408-4","article-title":"Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival","volume":"30","author":"Niwi\u0144ska A","year":"2013","unstructured":"Niwi\u0144ska A, Rudnicka H, Murawska M. Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival. Med Oncol. 2013, 30:408. 10.1007\/s12032-012-0408-4","journal-title":"Med Oncol"},{"key":"ref9","article-title":"Chapter 19: female genital system and breast","author":"Kumar V","year":"2018","unstructured":"Kumar V, Abbas AK, Aster JC. Chapter 19: female genital system and breast. Robbins Basic Pathology. 10th Ed. Kumar V, Abbas AK, Aster JC (ed): Elsevier, Amsterdam; 2018. 10:713-47."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1988.tb03249.x","article-title":"Cell binding function of E-cadherin is regulated by the cytoplasmic domain","volume":"7","author":"Nagafuchi A","year":"1988","unstructured":"Nagafuchi A, Takeichi M. Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J. 1988, 7:3679-84. 10.1002\/j.1460-2075.1988.tb03249.x","journal-title":"EMBO J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4603-3","article-title":"Differences in response and surgical management with neoadjuvant chemotherapy in invasive lobular versus ductal breast cancer","volume":"23","author":"Truin W","year":"2016","unstructured":"Truin W, Vugts G, Roumen RM, et al.. Differences in response and surgical management with neoadjuvant chemotherapy in invasive lobular versus ductal breast cancer. Ann Surg Oncol. 2016, 23:51-7. 10.1245\/s10434-015-4603-3","journal-title":"Ann Surg Oncol"},{"key":"ref12","unstructured":"Breast cancer stages. (2021). Accessed. June 1, 2023: https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/understanding-a-breast-cancer-diagnosis\/stages-of-breast-cancer.html."},{"key":"ref13","unstructured":"Treatment of stage IV (metastatic) breast cancer. (2023). Accessed. June 1, 2023: https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/treatment\/treatment-of-breast-cancer-by-stage\/treatment-of-stage-iv...."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1315::AID-CNCR14>3.0.CO;2-4","article-title":"Meningeal carcinomatosis in patients with breast carcinoma: clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen","volume":"77","author":"Fizazi K","year":"1996","unstructured":"Fizazi K, Asselain B, Vincent-Salomon A, et al.. Meningeal carcinomatosis in patients with breast carcinoma: clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen. Cancer. 1996, 77:1315-23. 10.1002\/(SICI)1097-0142(19960401)77:7&lt;1315::AID-CNCR14&gt;3.0.CO;2-4","journal-title":"Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/1756286419892360","article-title":"Safety of long-term intrathecal methotrexate in progressive forms of MS","volume":"12","author":"Stark JW","year":"2019","unstructured":"Stark JW, Josephs L, Dulak D, Clague M, Sadiq SA. Safety of long-term intrathecal methotrexate in progressive forms of MS. Ther Adv Neurol Disord. 2019, 12:10.1177\/1756286419892360","journal-title":"Ther Adv Neurol Disord"},{"key":"ref16","unstructured":"Trastuzumab. (2022). Accessed. August 15, 2023: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532246\/."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-008-0056-x","article-title":"Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine: a case report","volume":"16","author":"Shigekawa T","year":"2009","unstructured":"Shigekawa T, Takeuchi H, Misumi M, et al.. Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine: a case report. Breast Cancer. 2009, 16:88-92. 10.1007\/s12282-008-0056-x","journal-title":"Breast Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/167082-metastatic-leptomeningeal-carcinomatosis-from-primary-lobular-breast-cancer-found-in-a-medical-school-cadaveric-dissection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:21Z","timestamp":1707508701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/167082-metastatic-leptomeningeal-carcinomatosis-from-primary-lobular-breast-cancer-found-in-a-medical-school-cadaveric-dissection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.44533","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}